| 摘要 |
<p>594639 Disclosed is the use of human embryonic stem cells (hES) cells and/or their derivatives, said cells being free from animal products, feeder cells, growth factors other than beta-hCG and progesterone, leukaemia inhibiting factors, fibroblast growth factor, vitamin supplements, membrane associated steel factor, soluble steel factor and conditioned media, for the preparation of a medicament for the treatment of a subject with a disease, disorder, or condition selected from the group consisting of spinal cord injury, developmental disorders of the nervous system, degenerative disorders, familial nervous system disorders, nervous system trauma, cerebrovascular attack, skin disorders, bed sores, autoimmune disorders, genetic disorders, gangrene, conditions associated with ageing, diabetes mellitus, cardiovascular disorders, liver disorders, kidney disorders, fertility disorders, reproductive disorders, musculoskeletal disorders, eye disorders, lung disorders, hormone disorders, aphthous ulcers, other ulcers, and osteo-arthritis of the knee and hip joint, wherein the hES cells are not totipotent.</p> |
